CONTACT US   |  (864) 397-5101

SCbio Announces Accelerator Program For Emerging Life Science Companies, SCbioDrive

SOUTH CAROLINA – February 20, 2024 – SCbio, in partnership with MassBio, recently announced its new accelerator program, SCbioDrive, designed to advance emerging companies through expert business curricula, industry guidance and mentorship.

A biannual program, SCbioDrive will select up to six seed-stage therapeutic and medical device companies for an eight-week course, which will consist of seven weeks of virtual instruction followed by one week in person at SCbio facilities in Charleston, S.C. Company founders will complete industry-specific curriculum modules, led by experts from leading companies within the Palmetto State, which will include:

  • Business Planning & Commercialization
  • Fundraising
  • People Strategy & Operations
  • Drug Discovery & Therapeutics
  • Intellectual Property & Legal
  • Regulatory Strategy
  • Business Scaling

The program will conclude with an in-person demo day.

“SCbioDrive will give emerging life science companies a solid foundation of resources, increased access to capital and continued mentorship from a network of established business leaders,” said SCbio President and CEO James Chappell. “We want this program to show entrepreneurs that South Carolina is the state where businesses, at their earliest stages, are set up for success and sustained growth.”

“Our vision for Drive has always been to support diverse founders with exciting science no matter where they are starting their company,” said MassBio CEO & President Kendalle Burlin O’Connell. “We’re pleased to see SCbio take the MassBioDrive model and put a Palmetto State spin on it to accelerate their homegrown startups toward success.”

SCbioDrive will launch this fall. Applications for the inaugural program cohort will be available in June at www.scbio.org.  

SCbio is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. SCbio represents more than 1,000 organizations employing more than 87,000 professionals across the state and supports and advances organizations in multiple arenas including pharmaceuticals, medical devices and equipment, digital health, research and medical labs, bioscience distribution, bio-ag and more. For additional information about SCbio and the life sciences industry, visit www.SCbio.org.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.